REPRIEVE: Pitavastatin to Prevent Cardiovascular Disease in HIV
Conversations with CEI14 Sep 2023

REPRIEVE: Pitavastatin to Prevent Cardiovascular Disease in HIV

HIV patients are known to have up to a two-fold increase in heart-related events, compared with the general population. Could treatment with statins reduce this risk?

Dr. Steven Fine, an infectious disease specialist affiliated with the University of Rochester, reviews the recently published results of the REPRIEVE trial. The big picture is a 35% reduction in heart-related events. Dr. Fine digs into the details and statistics of the trial, and the encouraging results of statin treatment, even in those deemed to be at lower risk. Related Content:

Avsnitt(58)

“Where they feel honored as a human being.”

“Where they feel honored as a human being.”

[The following episode was initially recorded as part of "Any Positive Change", which has since merged with Conversations with CEI] The medical clinic at New York Harm Reduction Educators (NYHRE) prov...

22 Jan 202153min

”It‘s already rough out here.”

”It‘s already rough out here.”

[The following episode was initially recorded as part of "Any Positive Change", which has since merged with Conversations with CEI] Syringe service programs play a critical role in the lives of people...

13 Jan 202146min

Populärt inom Utbildning

rss-bara-en-till-om-missbruk-medberoende-2
historiepodden-se
det-skaver
nu-blir-det-historia
alska-oss
harrisons-dramatiska-historia
johannes-hansen-podcast
rss-viktmedicinpodden
roda-vita-rosen
not-fanny-anymore
sektledare
rss-sjalsligt-avkladd
allt-du-velat-veta
rss-max-tant-med-max-villman
sa-in-i-sjalen
i-vantan-pa-katastrofen
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-basta-livet
psykologsnack
sex-pa-riktigt-med-marika-smith